Personnel Information

写真a

HATANO Megumi


Job title

Assistant Professor
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2019.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Molecular Endocrinology and Metabolism， Graduate Student
  • 2019.04
    -
    2020.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Advanced Therapeutic Sciences， Department of Molecular Oncology， Visiting Lecturer
  • 2020.04
    -
    2021.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Advanced Therapeutic Sciences， Department of Molecular Oncology， Visiting Lecturer
  • 2021.05
    -
    2022.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Advanced Therapeutic Sciences， Department of Molecular Oncology， Visiting Lecturer
  • 2022.05
    -
    2022.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Advanced Therapeutic Sciences， Department of Molecular Oncology， Visiting Lecturer
  • 2022.10
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Molecular Oncology， Assistant Professor

▼display all

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • Japan Pediatric Society

  • The Japan Endocrine Society

  • The Japan Diabetes Society

  • The Japanese Society for Pediatric Endocrinology

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Doctor

To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Hatano Megumi, Tanase-Nakao Kanako, Uehara Erika, Iwano Reiko, Muroya Koji, Narumi Satoshi. Concurrent THRB and DUOX2 variants in a patient detected via newborn screening for congenital hypothyroidism: a case of resistance to thyroid hormone(タイトル和訳中) Clinical Pediatric Endocrinology. 2024.03; 33 (2): 94-100. ( ichushi )

  2. Hatano M, Tanase-Nakao K, Uehara E, Iwano R, Muroya K, Narumi S. Concurrent THRB and DUOX2 variants in a patient detected via newborn screening for congenital hypothyroidism: a case of resistance to thyroid hormone. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology. 2024; 33 (2): 94-100. ( PubMed, DOI )

  3. Hatano M, Akiyama Y, Shimada S, Yagi K, Akahoshi K, Itoh M, Tanabe M, Ogawa Y, Tanaka S. Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related hepatocellular carcinoma. Hepatology Communications. 2023.10; 7 (10): e0277.

  4. Hatano M, Akiyama Y, Shimada S, Yagi K, Akahoshi K, Itoh M, Tanabe M, Ogawa Y, Tanaka S. Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related HCC. Hepatology communications. 2023.10; 7 (10): ( PubMed, DOI )

  5. Tanimoto Eri, Hatano Megumi, Hosoya Yousuke, Yoshimoto Yuri, Hasegawa Daisuke, Manabe Atsushi, Ishida Yasushi, Ozawa Miwa. LATE EFFECTS ON GLUCOSE AND LIPID METABOLISM IN CHILDHOOD CANCER SURVIVORS PEDIATRIC BLOOD & CANCER. 2022.11; 69

  6. Hatano Megumi, Fukuzawa Ryuji, Hasegawa Yukihiro. The Mosaicism Ratio of 45,X May Explain the Phenotype in a Case of Mixed Gonadal Dysgenesis SEXUAL DEVELOPMENT. 2018; 12 (4): 175-179. ( PubMed, DOI )

  7. Hasegawa Yukihiro, Ariyasu Daisuke, Izawa Masako, Igaki-Miyamoto Junko, Fukuma Mami, Hatano Megumi, Yagi Hiroko, Goto Masahiro. Turner症候群におけるエチニルエストラジオールの漸増によって良好な最終身長は得られるが骨密度の獲得にはつながらない(Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD) Endocrine Journal. 2017.02; 64 (2): 221-227. ( ichushi )

  8. Hatano M, Migita T, Ohishi T, Shima Y, Ogawa Y, Morohashi KI, Hasegawa Y, Shibasaki F. SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1. Endocrine. 2016.11; 54 (2): 484-496. ( PubMed, DOI )

  9. Fukuma Mami, Ariyasu Daisuke, Hatano Megumi, Yagi Hiroko, Hasegawa Yukihiro. Wolfram症候群による早期発症泌尿器障害　新生児期に発症した1症例(Early-onset urological disorders due to Wolfram syndrome: A case of neonatal onset) Clinical Pediatric Endocrinology. 2016.04; 25 (2): 67-69. ( ichushi )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Shu Tsukihara, Yoshimitsu Akiyama, Shu Shimada, Megumi Hatano, Yusuke Kinugasa, Ken Eto, Shinji Tanaka. Histone H3 lysin 9 methyltransferase SETDB1 promotes gastric carcinogenesis by multiple signaling pathways. Digestive Disease Week 2023 2023.05.10 Chicago

  2. Tanimoto Eri, Hatano Megumi, Hosoya Yousuke, Yoshimoto Yuri, Hasegawa Daisuke, Manabe Atsushi, Ishida Yasushi, Ozawa Miwa. 包括的コホート研究による小児がんサバイバーの糖代謝・生活習慣の長期フォローアップ結果の検討(Late effects on glucose and lipid metabolism in childhood cancer survivors). 日本小児血液・がん学会雑誌 2022.10.01

  3. 右田 敏郎, 上田 彩乃, 大石 智一, 波多野 恵, 堀口 慎一郎, 古賀 文隆, 芝崎 太. 膀胱がんにおける上皮間葉移行を介した幹細胞性の獲得. 日本癌学会総会記事 2015.10.01

  4. Hirose Masakazu, Hashimura Kayako, Hatano Megumi, Kashihara Yoneo, Hashimoto Tomomi, Higashide Takashi, Aono Shigeo, Kawamura Tomoyuki. CGMは糖尿病治療に何をもたらしたか?　夢から実践へ　CGMを用いた糖尿病の新規治療法　後向きCGMからリアルタイムCGMへ(What did CGM bring to diabetes treatment? From dreams to actual practice　New therapy for diabetes using CGM: from Retrospective CGM to Real-time CGM). 糖尿病 2014.04.01

  5. Hatano Megumi, Ishikura Kenji, Sakai Tomoyuki, Hamasaki Yuko, Hataya Hiroshi, Ogata Kentaro, Fukuzawa Ryuji, Honda Masataka. 膜性増殖性糸球体腎炎I型の小児における完全寛解後の再発の繰り返し(Recurrent Relapses after Complete Remission in a Child with Membranoproliferative Glomerulonephritis Type I). 日本小児腎臓病学会雑誌 2011.06.01

To the head of this page.▲